Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

5.01
+0.13502.77%
Post-market: 5.010.0050+0.10%19:47 EDT
Volume:4.13M
Turnover:21.03M
Market Cap:431.49M
PE:-1.33
High:5.29
Open:4.98
Low:4.96
Close:4.87
52wk High:19.11
52wk Low:3.95
Shares:86.21M
Float Shares:60.67M
Volume Ratio:0.46
T/O Rate:6.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7642
EPS(LYR):-3.1667
ROE:-148.70%
ROA:-74.85%
PB:2.59
PE(LYR):-1.58

Loading ...

EyePoint Pharmaceuticals Q2 EPS $(1.09) Misses $(0.95) Estimate, Sales $507.000K Beat $406.857K Estimate

Benzinga Earnings
·
Aug 05

EyePoint Pharmaceuticals Q2 Revenue Drops on Lower License Income

Reuters
·
Aug 05

EyePoint Q2 FY26 Net Loss Widens to $94.47 Million; Revenue Drops to $507,000

Reuters
·
Aug 05

EyePoint Pharmaceuticals Q2 Basic EPS USD -1.09

THOMSON REUTERS
·
Aug 05

EyePoint Pharmaceuticals Q2 Product Sales USD 507 Thousand

THOMSON REUTERS
·
Aug 05

EyePoint Completes Enrollment in Phase 3 Duravyu Diabetic Macular Edema Trials COMO, CAPRI

Reuters
·
Jul 30

EyePoint (EYPT) Settles DOJ Claims, Is The 71% Undervaluation Case Convincing?

Simply Wall St.
·
Jul 30

EyePoint - Phase 3 Wet Amd Program Data Anticipated Beginning August 2026

THOMSON REUTERS
·
Jul 30

EyePoint - Topline Data for Dme Phase 3 Trials Anticipated in Q4 2027

THOMSON REUTERS
·
Jul 30

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of Duravyu™ for Treatment of Diabetic Macular Edema (Dme)

THOMSON REUTERS
·
Jul 30

Mizuho Raises Price Target on EyePoint Pharmaceuticals to $39 From $36, Keeps Outperform Rating

MT Newswires Live
·
Jul 29

EyePoint Pharmaceuticals (EYPT) Gets a Buy from Mizuho Securities

TIPRANKS
·
Jul 29

Did EyePoint's (EYPT) Federal Settlement and 5‑Year Integrity Deal Just Reframe Its Risk Profile?

Simply Wall St.
·
Jul 28

Eyepoint Enters Settlement Agreement with DOJ, Oig-hhs, and DHA - SEC Filing

Reuters
·
Jul 18

EyePoint Pharmaceuticals Settles DEXYCU Case, Enhances Compliance Oversight

TIPRANKS
·
Jul 18

Eyepoint - to Pay $166,500 for Attorneys' Fees and Costs - SEC Filing

THOMSON REUTERS
·
Jul 18

Eyepoint - Enters Corporate Integrity Agreement with Oig-hhs on July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 18

Eyepoint - to Pay $4.68 Mln Plus Interest in Settlement - SEC Filing

THOMSON REUTERS
·
Jul 18

Eyepoint - Enters Settlement Agreement with DOJ, Oig-hhs, and Dha on July 17, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 18

EyePoint to pay $4.6M to resolve False Claim Act allegations

TIPRANKS
·
Jul 17